Home Reimbursed medicines Paliperidon

Paliperidon — maximum prices and reimbursement

The CANAMED catalogue contains 66 medicines with the active substance Paliperidon, from 7 manufacturers. Below you can see each entry with the brand name, the manufacturer, the maximum retail price, the reimbursement percentage and the prescription status — plus live pharmacy prices, where we track them.

66 CANAMED entries
7 Manufacturers
131.12–6648.92 Maximum price (RON)
16 With a reimbursement percentage
Search live prices → All reimbursed medicines →

In short: for the active substance Paliperidon there are 66 authorised medicines in the CANAMED catalogue, with maximum retail prices between 131.12 and 6648.92 RON, from 7 manufacturers. For 16 of them the catalogue also records the reimbursement percentage. The maximum price is the legal cap — pharmacies may sell below it, so it is worth comparing the real price before you go. Latest import: 2026-11-03.

Data verified on from public sources (OpenStreetMap, chain websites, ANM/MS) — updated daily.

CANAMED catalogue

All medicines with Paliperidon

Maximum retail price = the legal selling cap. Sorted by price, lowest first.

Brand name Manufacturer Maximum price Reimbursement Prescription
PARNIDO 3 mg KRKA, D.D., NOVO MESTO - SLOVENIA 131.12 RON 100% · C1 (certain chronic diseases)
CNAS pays ~131.12 RON; you ~0.00 RON*		 PRF
PARNIDO 6 mg KRKA, D.D., NOVO MESTO - SLOVENIA 250.23 RON 100% · C1 (certain chronic diseases)
CNAS pays ~250.23 RON; you ~0.00 RON*		 PRF
PARNIDO 9 mg KRKA, D.D., NOVO MESTO - SLOVENIA 250.23 RON 100% · C1 (certain chronic diseases)
CNAS pays ~250.23 RON; you ~0.00 RON*		 PRF
XEPLION JANSSEN PHARMACEUTICA N.V. - BELGIA 441.71 RON 100% · C1 (certain chronic diseases)
CNAS pays ~441.71 RON; you ~0.00 RON*		 PRF
PALIPERIDONA TEVA 75 mg ACTAVIS GROUP PTC EHF. - ISLANDA 485.32 RON 100% · C1 (certain chronic diseases)
CNAS pays ~485.32 RON; you ~0.00 RON*		 PRF
XEPLION JANSSEN PHARMACEUTICA N.V. - BELGIA 489.80 RON 100% · C1 (certain chronic diseases)
CNAS pays ~489.80 RON; you ~0.00 RON*		 PRF
PALIPERIDONA TEVA 50 mg ACTAVIS GROUP PTC EHF. - ISLANDA 495.72 RON not reimbursed PRF
PALIPERIDONA TEVA 100 mg ACTAVIS GROUP PTC EHF. - ISLANDA 570.87 RON 100% · C1 (certain chronic diseases)
CNAS pays ~570.87 RON; you ~0.00 RON*		 PRF
XEPLION JANSSEN PHARMACEUTICA N.V. - BELGIA 629.07 RON 100% · C1 (certain chronic diseases)
CNAS pays ~629.07 RON; you ~0.00 RON*		 PRF
PALIPERIDONA TEVA 150 mg ACTAVIS GROUP PTC EHF. - ISLANDA 802.69 RON 100% · C1 (certain chronic diseases)
CNAS pays ~802.69 RON; you ~0.00 RON*		 PRF
XEPLION JANSSEN PHARMACEUTICA N.V. - BELGIA 920.51 RON 100% · C1 (certain chronic diseases)
CNAS pays ~920.51 RON; you ~0.00 RON*		 PRF
TREVICTA 175 mg JANSSEN PHARMACEUTICA N.V. - BELGIA 1460.08 RON 100% · C1 (certain chronic diseases)
CNAS pays ~1460.08 RON; you ~0.00 RON*		 PRF
TREVICTA 263 mg JANSSEN PHARMACEUTICA N.V. - BELGIA 1496.12 RON 100% · C1 (certain chronic diseases)
CNAS pays ~1496.12 RON; you ~0.00 RON*		 PRF
TREVICTA 350 mg JANSSEN PHARMACEUTICA N.V. - BELGIA 2005.59 RON 100% · C1 (certain chronic diseases)
CNAS pays ~2005.59 RON; you ~0.00 RON*		 PRF
TREVICTA 525 mg JANSSEN PHARMACEUTICA N.V. - BELGIA 2972.13 RON 100% · C1 (certain chronic diseases)
CNAS pays ~2972.13 RON; you ~0.00 RON*		 PRF
BYANNLI 700 mg JANSSEN PHARMACEUTICA N.V. - BELGIA 4585.70 RON 100% · C1 (certain chronic diseases)
CNAS pays ~4585.70 RON; you ~0.00 RON*		 PRF
BYANNLI 1000 mg JANSSEN PHARMACEUTICA N.V. - BELGIA 6648.92 RON 100% · C1 (certain chronic diseases)
CNAS pays ~6648.92 RON; you ~0.00 RON*		 PRF
INVEGA 12 mg JANSSEN-CILAG SPA - ITALIA — not reimbursed P-RF
INVEGA 12 mg JANSSEN-CILAG SPA - ITALIA — not reimbursed P-RF
INVEGA 12 mg JANSSEN-CILAG SPA - ITALIA — not reimbursed P-RF
INVEGA 12 mg JANSSEN-CILAG SPA - ITALIA — not reimbursed P-RF
INVEGA 12 mg JANSSEN-CILAG SPA - ITALIA — not reimbursed P-RF
INVEGA 12 mg JANSSEN-CILAG SPA - ITALIA — not reimbursed P-RF
INVEGA 12 mg JANSSEN-CILAG SPA - ITALIA — not reimbursed P-RF
INVEGA 12 mg JANSSEN-CILAG SPA - ITALIA — not reimbursed P-RF
INVEGA 12 mg JANSSEN-CILAG SPA - ITALIA — not reimbursed P-RF
INVEGA 12 mg JANSSEN-CILAG SPA - ITALIA — not reimbursed P-RF
INVEGA 12 mg JANSSEN-CILAG SPA - ITALIA — not reimbursed P-RF
INVEGA 12 mg JANSSEN-CILAG SPA - ITALIA — not reimbursed P-RF
INVEGA 12 mg JANSSEN-CILAG SPA - ITALIA — not reimbursed P-RF
INVEGA 12 mg JANSSEN-CILAG SPA - ITALIA — not reimbursed P-RF
INVEGA 12 mg JANSSEN-CILAG SPA - ITALIA — not reimbursed P-RF
INVEGA 12 mg JANSSEN-CILAG SPA - ITALIA — not reimbursed P-RF
MOPETIA 100 mg PHARMASCIENCE INTERNATIONAL LIMITED - CIPRU — not reimbursed PRF
MOPETIA 150 mg PHARMASCIENCE INTERNATIONAL LIMITED - CIPRU — not reimbursed PRF
MOPETIA 50 mg PHARMASCIENCE INTERNATIONAL LIMITED - CIPRU — not reimbursed PRF
MOPETIA 75 mg PHARMASCIENCE INTERNATIONAL LIMITED - CIPRU — not reimbursed PRF
PALIPERIDONA STADA 100 mg STADA ARZNEIMITTEL AG - GERMANIA — not reimbursed PRF _X0002_
PALIPERIDONA STADA 150 mg STADA ARZNEIMITTEL AG - GERMANIA — not reimbursed PRF _X0002_
PALIPERIDONA STADA 25 mg STADA ARZNEIMITTEL AG - GERMANIA — not reimbursed PRF _X0002_
PALIPERIDONA STADA 50 mg STADA ARZNEIMITTEL AG - GERMANIA — not reimbursed PRF _X0002_
PALIPERIDONA STADA 75 mg STADA ARZNEIMITTEL AG - GERMANIA — not reimbursed PRF _X0002_
PALMEUX 100 mg PHARAMATHEN S.A. - GRECIA — not reimbursed PRF
PALMEUX 150 mg PHARAMATHEN S.A. - GRECIA — not reimbursed PRF
PALMEUX 25 mg PHARAMATHEN S.A. - GRECIA — not reimbursed PRF
PALMEUX 50 mg PHARAMATHEN S.A. - GRECIA — not reimbursed PRF
PALMEUX 75 mg PHARAMATHEN S.A. - GRECIA — not reimbursed PRF
PARNIDO 3 mg KRKA, D.D., NOVO MESTO - SLOVENIA — not reimbursed PRF
PARNIDO 3 mg KRKA, D.D., NOVO MESTO - SLOVENIA — not reimbursed PRF
PARNIDO 3 mg KRKA, D.D., NOVO MESTO - SLOVENIA — not reimbursed PRF
PARNIDO 3 mg KRKA, D.D., NOVO MESTO - SLOVENIA — not reimbursed PRF
PARNIDO 3 mg KRKA, D.D., NOVO MESTO - SLOVENIA — not reimbursed PRF
PARNIDO 3 mg KRKA, D.D., NOVO MESTO - SLOVENIA — not reimbursed PRF
PARNIDO 6 mg KRKA, D.D., NOVO MESTO - SLOVENIA — not reimbursed PRF
PARNIDO 6 mg KRKA, D.D., NOVO MESTO - SLOVENIA — not reimbursed PRF
PARNIDO 6 mg KRKA, D.D., NOVO MESTO - SLOVENIA — not reimbursed PRF
PARNIDO 6 mg KRKA, D.D., NOVO MESTO - SLOVENIA — not reimbursed PRF
PARNIDO 6 mg KRKA, D.D., NOVO MESTO - SLOVENIA — not reimbursed PRF
PARNIDO 6 mg KRKA, D.D., NOVO MESTO - SLOVENIA — not reimbursed PRF
PARNIDO 9 mg KRKA, D.D., NOVO MESTO - SLOVENIA — not reimbursed PRF
PARNIDO 9 mg KRKA, D.D., NOVO MESTO - SLOVENIA — not reimbursed PRF
PARNIDO 9 mg KRKA, D.D., NOVO MESTO - SLOVENIA — not reimbursed PRF
PARNIDO 9 mg KRKA, D.D., NOVO MESTO - SLOVENIA — not reimbursed PRF
PARNIDO 9 mg KRKA, D.D., NOVO MESTO - SLOVENIA — not reimbursed PRF
PARNIDO 9 mg KRKA, D.D., NOVO MESTO - SLOVENIA — not reimbursed PRF
XEPLION JANSSEN PHARMACEUTICA N.V. - BELGIA — not reimbursed PRF

Reimbursement and amounts come from the CNAS nomenclature (SIUI) valid in the current month, for each pack. *What you pay is indicative: the maximum price minus what CNAS pays on the main sublist, for an insured adult. The pharmacy may sell below the maximum price; low-income pensioners, children, pupils and pregnant women may pay less. C1 applies only to the diseases on the list, and C2 within the national programmes.

Prescription status key:

  • PRF — With a medical prescription kept by the pharmacy (P-RF)
  • P-RF — With a medical prescription kept by the pharmacy (P-RF)
  • PRF _X0002_ — With a medical prescription (PRF _X0002_)

Live pharmacy prices

Products with Paliperidon in our comparator

Shelf prices collected from the large chains — see on each product page where it is cheapest.

Good to know

How to read the maximum price

The CANAMED maximum retail price is the legal cap approved by the Ministry of Health — the pharmacy may sell for less, never for more. If the medicine is reimbursed, the sublist percentage (A 90%, B 50%, C1/C2 100%, D 20%) applies to the reference price of the therapeutic group, usually calculated from the cheapest product with the same INN — which is why your contribution can differ from one brand to another, even for the same active substance. The electronic prescription automatically shows the exact amount to pay; for non-prescription shelf prices, use the HartaFarmacii comparator.

CANAMED catalogue

Other active substances in the catalogue

See also the full list of reimbursed medicines, with an alphabetical index of all active substances.

Frequently asked questions

FAQ · Paliperidon

  1. Is Paliperidon reimbursed?
    Yes. For 16 of the catalogue entries with Paliperidon we have the reimbursement percentage on record. The percentage depends on the CNAS sublist each product is placed on (A 90%, B 50%, C1/C2 100%, D 20%) and applies to the reference price of the therapeutic group, not to the shelf price. Ask the doctor or pharmacist for the exact placement.
  2. What is the CANAMED maximum price for Paliperidon?
    The maximum retail prices (the CANAMED legal cap) for medicines with Paliperidon are between 131.12 and 6648.92 RON. No pharmacy may sell above the maximum price, but it may sell below it — compare real prices with the HartaFarmacii comparator.
  3. What percentage of Paliperidon is reimbursed?
    The percentage depends on the CNAS sublist: A 90% (common chronic diseases), B 50% (partial reimbursement), C1 and C2 100% (serious chronic diseases and national programmes), D 20%. The percentage applies to the reference price set by CNAS, not to the shelf price, so you may pay a difference even for a “100% reimbursed” medicine. You can see the exact placement on the electronic prescription.
  4. How many medicines with Paliperidon are in the CANAMED catalogue?
    The CANAMED catalogue holds 66 authorised medicines with the active substance Paliperidon — different brand names, strengths and pharmaceutical forms. You will find them all, with maximum price and prescription status, in the table on this page. Latest CANAMED import into the HartaFarmacii database: 2026-11-03.

Before you go

Find the best price for Paliperidon

Compare prices →